![A nurse gives a thumbs up at Manama's repurposed convention centre, in which 6,000 people are participating in a large-scale trial of a Chinese-sponsored vaccine for the Covid-19 coronavirus, on August 27, 2020 in the Bahraini capital. - Chinese drug giant Sinopharm began testing the inactivated COVID-19 jab in Bahrain earlier this month after starting a similar trial on 15,000 subjects in the nearby United Arab Emirates in July. The current phase of the study, in which the vaccine's efficacy and safety is tested in a large cross-section of the population, is due to last until July 2021. (Photo by Mazen Mahdi / AFP)](https://thenational-the-national-prod.cdn.arcpublishing.com/resizer/v2/5AU36WFDOY76EKGQY7EUQU7W2A.jpg?smart=true&auth=29552a2a9c9d75ae99b66384a96134beba83158798ab8afe9bb1da9c818d73f8&width=400&height=225)
Manama’s convention centre was turned into a field hospital. AFP
Manama’s convention centre was turned into a field hospital. AFP
Bahrain approves use of Pfizer-BioNTech Covid vaccine
The country becomes the second globally to authorise use after UK
![The National](https://thenational-the-national-prod.cdn.arcpublishing.com/resizer/v2/https%3A%2F%2Fs3.amazonaws.com%2Farc-authors%2Fthenational%2F9e2159fa-e4db-4215-b498-6b3607b75bee.png?smart=true&auth=cf728de2f2d93afc214682199f23d53c844677eb59567fe99abdb1c7e9f03161&width=70&height=70)
The National
05 December, 2020